Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NGL FINE CHM Plunges 4%; BSE HEALTHCARE Index Up 0.8%
Wed, 21 Aug 13:24

NGL FINE CHM Plunges 4%; BSE HEALTHCARE Index Up 0.8%Image source: Nikada/www.istockphoto.com

NGL FINE CHM share price has plunged 4% and is presently trading at Rs 2,351.9.

Meanwhile, the BSE HEALTHCARE index is at 41,949.3 (up 0.8%).

Among the top losers in the BSE HEALTHCARE index today are Aurobindo Pharma (down 2.7%) and Procter & Gamble Health (down 1.3%).

GSK Pharma (up 5.1%) and SUVEN PHARMACEUTICALS (up 4.4%) are among the top gainers today.

Over the last one year, NGL FINE CHM has moved up from Rs 1,986.7 to Rs 2,351.9, registering a gain of Rs 365.2 (up 18.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,021.8 to 41,949.3, registering a gain of 49.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 129.9%), GSK Pharma (up 117.0%) and Glenmark Pharma (up 115.7%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,685.2 (down 0.1%).

The top losers among the BSE Sensex today are Ultratech Cement (down 1.6%) and Tata Steel (down 1.1%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.

In the meantime, NSE Nifty is at 24,704.2 . Divis Laboratories and Titan are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,216.1 to 80,685.2, registering a gain of 15,469.1 points (up 23.7%).

NGL FINE CHM Financial Update...

NGL FINE CHM net profit grew 8.4% YoY to Rs 92 million for the quarter ended June 2024, compared to a profit of Rs 85 million a year ago. Net sales rose 27.7% to Rs 908 million during the period as against Rs 710 million in April-June 2023.

For the year ended March 2024, NGL FINE CHM reported 101.6% increase in net profit to Rs 413 million compared to net profit of Rs 205 million during FY23. Revenue of the company grew 21.8% to Rs 3,387 million during FY24.

The current Price to earnings ratio of NGL FINE CHM, based on rolling 12 month earnings, stands at 34.5.


Equitymaster requests your view! Post a comment on "NGL FINE CHM Plunges 4%; BSE HEALTHCARE Index Up 0.8%". Click here!